Have a feature idea you'd love to see implemented? Let us know!

INAB In8Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INAB

Price (delayed)

$0.2827

Market cap

$13.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.83

Enterprise value

$8.91M

Highlights
The EPS has increased by 32% YoY and by 9% QoQ
In8Bio's quick ratio has plunged by 52% YoY and by 37% from the previous quarter
In8Bio's equity has decreased by 38% YoY and by 22% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.in8bio.com
Peers: OLMA OMER OMGA ONCT

Key stats

What are the main financial stats of INAB
Market
Shares outstanding
46.79M
Market cap
$13.23M
Enterprise value
$8.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.92
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$31.96M
EBITDA
-$29.42M
Free cash flow
-$24.88M
Per share
EPS
-$0.83
Free cash flow per share
-$0.55
Book value per share
$0.31
Revenue per share
$0
TBVPS
$0.5
Balance sheet
Total assets
$22.5M
Total liabilities
$8.88M
Debt
$5.9M
Equity
$13.62M
Working capital
$7.92M
Liquidity
Debt to equity
0.43
Current ratio
2.66
Quick ratio
2.15
Net debt/EBITDA
0.15
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-118.4%
Return on equity
-173.1%
Return on invested capital
-238.1%
Return on capital employed
-180.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INAB stock price

How has the In8Bio stock price performed over time
Intraday
-13.81%
1 week
23.5%
1 month
-8.18%
1 year
-69.6%
YTD
-79.51%
QTD
4.7%

Financial performance

How have In8Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32.1M
Net income
-$31.96M
Gross margin
N/A
Net margin
N/A
INAB's operating income is down by 5% year-on-year and by 3.1% since the previous quarter
INAB's net income is down by 5% YoY and by 2.9% from the previous quarter

Growth

What is In8Bio's growth rate over time

Valuation

What is In8Bio stock price valuation
P/E
N/A
P/B
0.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 32% YoY and by 9% QoQ
INAB's P/B is 54% below its last 4 quarters average of 2.3
In8Bio's equity has decreased by 38% YoY and by 22% from the previous quarter

Efficiency

How efficient is In8Bio business performance
The return on equity has declined by 29% year-on-year and by 14% since the previous quarter
The ROA has decreased by 22% YoY and by 10% from the previous quarter
In8Bio's ROIC has decreased by 9% YoY and by 5% from the previous quarter

Dividends

What is INAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INAB.

Financial health

How did In8Bio financials performed over time
The total assets is 153% greater than the total liabilities
In8Bio's quick ratio has plunged by 52% YoY and by 37% from the previous quarter
The company's current ratio fell by 48% YoY and by 35% QoQ
In8Bio's debt is 57% less than its equity
In8Bio's debt to equity has surged by 65% YoY and by 30% QoQ
In8Bio's equity has decreased by 38% YoY and by 22% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.